All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| CLDI / Calidi Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| US09001T1144 / Bilander Acquisition Corp.
|
|
|
|
|
|
|
|
| US56608A1135 / Marblegate Acquisition Corp.
|
|
|
|
|
|
|
|
| BRIDGETOWN HOLDINGS LTD
/ *W EXP 09/30/202 (G1355U121) |
|
|
|
|
|
|
|
| CLVT / Clarivate Plc
|
|
|
|
|
|
|
|
| APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| US21289P1104 / Conyers Park III Acquisition Corp.
|
|
|
|
|
|
|
|
| CLDI.WS / First Light Acquisition Group, Inc. - Equity Warrant
|
|
|
|
|
|
|
|
| CCV.WS / Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exer
|
|
|
|
|
|
|
|
| LSBPW / LakeShore Biopharma Co., Ltd - Equity Warrant
|
|
|
|
|
|
|
|
| SAGE / Sage Therapeutics, Inc.
|
|
|
|
|
|
|
|
| KYG638361116 / Swiftmerge Acquisition Corp.
|
|
|
|
|
|
|
|
| AAC.WS / Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ord
|
|
|
|
|
|
|
|
| BHC / Bausch Health Companies Inc.
|
|
|
|
|
|
|
|
| AFTR.WS / AfterNext HealthTech Acquisiti Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
|
|
|
|
|
|
|
|
| CORS.WS / Corsair Partnering Corporation Redeemable warrants, each whole warrant exercisable for one Class A o
|
|
|
|
|
|
|
|
| MORF / Morphic Holding, Inc.
|
|
|
|
|
|
|
|
| FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CCVI.WS / Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exe
|
|
|
|
|
|
|
|
| US43734R1115 / Home Plate Acquisition Corp.
|
|
|
|
|
|
|
|
| CERE / Cerevel Therapeutics Holdings, Inc.
|
|
|
|
|
|
|
|
| ROSS.WS / Ross Acquisition Corp II - Equity Warrant
|
|
|
|
|
|
|
|
| CRNX / Crinetics Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| RVMD / Revolution Medicines, Inc.
|
|
|
|
|
|
|
|
| PRTA / Prothena Corporation plc
|
|
|
|
|
|
|
|
| CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
| SWTX / SpringWorks Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ARVN / Arvinas, Inc.
|
|
|
|
|
|
|
|
| MLTX / MoonLake Immunotherapeutics
|
|
|
|
|
|
|
|
| / Compass Digital Acquisition Corp
|
|
|
|
|
|
|
|
| TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CVII.WS / Churchill Capital Corp VII - Equity Warrant
|
|
|
|
|
|
|
|
| GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SLDB / Solid Biosciences Inc.
|
|
|
|
|
|
|
|
| ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| CNDA.WS / Concord Acquisition Corp II - Equity Warrant
|
|
|
|
|
|
|
|
| RLAY / Relay Therapeutics, Inc.
|
|
|
|
|
|
|
|
